Evidence map›Paper›PMID 25538867›Full record

ArticlePeerJ2014

Arterial spin labeling versus BOLD in direct challenge and drug-task interaction pharmacological fMRI.

Stephanie B Stewart, Jonathan M Koller, Meghan C Campbell, Kevin J Black

Abstract read
In one paragraph

Article in PeerJ, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Trial
  2. Region- and time- specific effects of ketamine on cerebral blood flow: a randomized controlled trial.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2023
    Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Stephanie B StewartDepartment of Psychiatry, Washington University School of Medicine , St Louis, MO , USA ; Department of Neurology, Washington University School of Medicine , St Louis, MO , USA.
Jonathan M KollerDepartment of Psychiatry, Washington University School of Medicine , St Louis, MO , USA.
Meghan C CampbellDepartment of Neurology, Washington University School of Medicine , St Louis, MO , USA ; Department of Radiology, Washington University School of Medicine , St Louis, MO , USA.
Kevin J BlackDepartment of Psychiatry, Washington University School of Medicine , St Louis, MO , USA ; Department of Neurology, Washington University School of Medicine , St Louis, MO , USA ; Department of Radiology, Washington University School of Medicine , St Louis, MO , USA ; Department of Anatomy and Neurobiology, Washington University School of Medicine , St Louis, MO , USA ; Division of Biology and Biomedical Sciences, Washington University School of Medicine , St Louis, MO , USA.

Funding

Washington University Institute of Clinical and Translational Sciences (UL1)UL1RR024992 · NCRR · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2007 to 2011
$45.4M
Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
BIOMEDICAL RESEARCH TRAINING IN DRUG ABUSET32DA007261 · NIDA · WASHINGTON UNIVERSITY · PI ARPANA AGRAWAL, Jose A Moron-Concepcion · 1991 to 2026
$8.8M
proj 3 - NINDS INSTIUTIONAL CENTER CORE GRANTS TO SUPPORT NEUROSCIENCE RESEARP30NS048056 · NINDS · WASHINGTON UNIVERSITY · PI MINTUN, MARK A. · 2004 to 2014
$7.4M
Task Specific Project 3: Diffuse Optical TomographyU54CA136398 · NCI · WASHINGTON UNIVERSITY · PI ACHILEFU, SAMUEL · 2008 to 2012
$6.0M
RES FACIL CONST: NEUROSCIENCE: LANGUAGE, COGNITION &BEHAVIOR, PAIN, DEPRESSIONC06RR020092 · NCRR · WASHINGTON UNIVERSITY · PI STANLEY, SAMUEL · 2004 to 2004
$1.6M
Training New Investigators in Neuroimaging and in the Neuropsychiatry of MovementK24MH087913 · NIMH · WASHINGTON UNIVERSITY · PI BLACK, KEVIN J · 2010 to 2014
$818k
NCATS NIH HHS UL1 TR000448NCI NIH HHS U54 CA136398NCRR NIH HHS C06 RR020092NCRR NIH HHS UL1 RR024992NIDA NIH HHS T32 DA007261NIMH NIH HHS K24 MH087913NINDS NIH HHS P30 NS048056
6 · The paper itself

Abstract

A carefully controlled study allowed us to compare the sensitivity of ASL (arterial spin labeling) and BOLD (blood oxygen level dependent) fMRI for detecting the effects of the adenosine A2a antagonist tozadenant in Parkinson disease. The study compared the effect of drug directly or the interaction of the drug with a cognitive task. Only ASL detected the direct effect of tozadenant. BOLD was more sensitive to the cognitive task, which (unlike most drugs) allows on-off comparisons over short periods of time. Neither ASL nor BOLD could detect a cognitive-pharmacological interaction. These results are consistent with the known relative advantages of each fMRI method, and suggest that for drug development, directly imaging pharmacodynamic effects with ASL may have advantages over cognitive-pharmacological interaction BOLD, which has hitherto been the more common approach to pharmacological fMRI.

Indexed as

Arterial spin labeling (ASL)BOLDFunctional magnetic resonance imagingParkinson diseasephMRI (pharmacological fMRI)Pulsed arterial spin labelingStatistical parametric mappingTozadenant

Identifiers

PMID25538867
PMCPMC4266850

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.